Radiation oncologists hit hard after Medicare cuts, ASTRO survey finds

PanTracer LBx liquid biopsy profiling test receives Medicare coverage

NeoGenomics announced the PanTracer LBx test has received coverage from CMS’ Molecular Diagnostics Services Program under Local Coverage Determination - MolDX: Plasma-Based Genomic Profiling in Solid Tumors.

March 20, 2026

Vol.52 No.11

Clinical Trials & Tribulations

Supportive cancer care is the smart investment our leaders in Washington can’t afford to ignore

In the United States, 18.6 million people are living with cancer, and nearly 40% of Americans will face a cancer diagnosis in their lifetime.

January 30, 2026

Vol.52 No.04

By Les Biller

In the Archives

Bernie Lewinsky’s collection of artifacts captures “the learning curve” of radiation oncology

Over his five decades as a radiation oncologist, Bernie Lewinsky has been collecting the relics of radiotherapy.

January 23, 2026

Vol.52 No.03

By Sara Willa Ernst

Clinical Trials & Tribulations

A radiation oncologist’s perspective: Why we need to accelerate early detection strategies for lung cancers

As a radiation oncologist, I am struck by how often the decisive variable in lung cancer is not the sophistication of our therapy, but the timing of our encounter with the disease. The American Cancer Society projects 618,120 cancer deaths in the United States in 2025, with lung cancer remaining as the single largest contributor,...

January 16, 2026

Vol.52 No.02

By Kevin King

Drugs & Targets

Kallisio partners with Stanford Health Care on rollout of Stentra system for head-and-neck radiation therapy

Kallisio has collaborated with Stanford Health Care to support the clinical implementation of its FDA-cleared Stentra system for use in head-and-neck cancer radiation therapy.

January 09, 2026

Vol.52 No.1

Cancer Policy

AI will determine Medicare prior authorizations in six states under new pilot program

Medicare will soon launch a pilot program that will test the use of AI to automate the prior authorization process—a tool that will recommend whether to approve or deny coverage for a patient in the program.

December 12, 2025

Vol.51 No.45

By Sara Willa Ernst

Radiation oncologists hit hard after Medicare cuts, ASTRO survey finds

YOU MAY BE INTERESTED IN

PanTracer LBx liquid biopsy profiling test receives Medicare coverage

Supportive cancer care is the smart investment our leaders in Washington can’t afford to ignore

Bernie Lewinsky’s collection of artifacts captures “the learning curve” of radiation oncology

A radiation oncologist’s perspective: Why we need to accelerate early detection strategies for lung cancers

Kallisio partners with Stanford Health Care on rollout of Stentra system for head-and-neck radiation therapy

AI will determine Medicare prior authorizations in six states under new pilot program

Renew today!

Subscriber content

Never miss an issue!

Login